Stocks and InvestingStocks and Investing
Wed, October 26, 2022
Tue, October 25, 2022
Mon, October 24, 2022

Jessica Fye Maintained (VRTX) at Buy with Increased Target to $327 on, Oct 24th, 2022


Published on 2024-10-27 23:35:48 - WOPRAI, Jessica Fye
  Print publication without navigation


Jessica Fye of JP Morgan, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $319 to $327 on, Oct 24th, 2022.

Jessica has made no other calls on VRTX in the last 4 months.



There are 9 other peers that have a rating on VRTX. Out of the 9 peers that are also analyzing VRTX, 5 agree with Jessica's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $276 on, Friday, September 2nd, 2022
  • Do Kim of "Piper Sandler" Maintained at Hold with Increased Target to $288 on, Wednesday, August 17th, 2022
  • Paul Matteis of "Stifel" Maintained at Hold and Held Target at $263 on, Wednesday, August 10th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $253 on, Monday, August 8th, 2022
  • Brian Skorney of "Baird" Maintained at Hold and Held Target at $250 on, Friday, August 5th, 2022


These are the ratings of the 4 analyists that currently disagree with Jessica


  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $337 on, Friday, October 21st, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Friday, August 5th, 2022
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $307 on, Friday, August 5th, 2022
  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $365 on, Wednesday, July 13th, 2022